Approval · Notice of Compliance 2168 · 2001
DDAVP: Notice of Compliance 2168
Issued April 17, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2168
- Date
- April 17, 2001
- Company
- Ferring Inc.North York, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the product monograph
- Therapeutic class
- Antidiuretic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DDAVP | Not yet assigned | — |
Medicinal ingredients
- DESMOPRESSIN ACETATE 10 MCG per ACT
- DESMOPRESSIN ACETATE 0.1 MG per ML